Comparison study between sitagliptin and vildagliptin on the glucose fluctuation and endothelial function

Comparison study between sitagliptin and vildagliptin on the glucose fluctuation and endothelial function - Comparison study between sitagliptin and vildagliptin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012137

Enrollment

Registered

2013-10-28

Start date

2013-10-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

sitagliptin 50mg vildagliptin 100mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ty2 2 DM in an inadequate BS control(over than HbA1c6.5%) under 50mg sitagliptin treatment

Exclusion criteria

Exclusion criteria: insulin treatment, liver or renal dysfunction

Design outcomes

Primary

Measure	Time frame
CGM(BS average, SD, MAGE) and Endopat	—

Countries

Japan

Contacts

Public ContactYoshikazu Sumitani

Kyorin University of Medicine Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism

sumitani@ks.kyorin-u.ac.jp042-247-5512

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026